
OIG and CMS Clash on Medicare Overpayment Recoveries
OIG says the agency is leaving millions of dollars on the table, but CMS doesn’t want to hear it.
OIG says the agency is leaving millions of dollars on the table, but CMS doesn’t want to hear it.
With the final rule on PT published July 11, here are the five things lab managers need to know to keep their labs compliant.
D.C. Circuit Court of Appeals agrees with lab industry that CMS got Medicare lab pricing all wrong, but says it’s unable to intervene.
Here are the aspects of the proposed rule most likely to have an impact on labs and the businesses that own them.
After years of resistance, the lab industry’s hopes and prayers for relief from the flawed pricing scheme may soon be answered.